SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following the announcement of a private debt exchange that will convert 1.4 billion dollars in senior notes into equity, a move intended to clean up the balance sheet but sparking concerns regarding shareholder dilution. The community is sharply divided, with some investors debating if this is a strategic move to clear debt for a future acquisition, while others express frustration over the impact on share value and the ongoing performance of the stock.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is seeing heightened volatility and intense debate among investors ahead of its earnings report, with community sentiment split between bulls expecting a blowout growth performance and bears calling for a valuation correction. Much of the discourse focuses on whether Palantir's AI-driven commercial expansion and government contract momentum can justify its high valuation multiple against rising institutional skepticism.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is currently trending as retail investors speculate on a major volatility event surrounding the upcoming earnings report and the potential market impact of its new AI-enabled AR glasses. Community discussion is sharply divided between those betting on a speculative re-rating due to a low valuation and those frustrated by leadership's governance, persistent share price weakness, and legal headwinds.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is surging as investors react to a positive 10-3 advisory committee vote supporting the efficacy of its melanoma therapy, significantly boosting sentiment ahead of the upcoming FDA decision. The community is actively debating the likelihood of a final approval versus a potential regulatory rejection, with heavy focus on the high short interest driving potential squeeze dynamics.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is experiencing a surge in trading volume and social media discussion as investors express confidence in the company's Briumvi MS franchise, leading to speculation about a potential buyout. While some community members remain wary of short-term volatility and analyst price targets, the prevailing sentiment is bullish, driven by the prospect of upcoming earnings and future potential for subcutaneous treatment indications.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is facing significant downward pressure and setting new lows as investors grapple with uncertainty ahead of the upcoming earnings report. The community remains deeply divided, with bulls viewing the stock as a generational value opportunity given the brand's market share, while bears cite concerns over decelerating growth and ongoing margin pressures.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as investors digest news of its collaboration with Duolingo and anticipate upcoming Q2 financial results, with sentiment heavily focused on its rapid store expansion versus competitive pressures in China. The community remains deeply divided, with long-term bulls highlighting robust growth metrics and share buybacks while bears continue to scrutinize margin sustainability and the stock's OTC listing status.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron is attracting intense attention as shifting reports on a potential resolution to the U.S.-Iran conflict spark volatility in global oil prices and supply chain outlooks. The community is actively debating the stock's long-term value, with many investors weighing the company's strong dividend and cash flow against broader sector pressures and geopolitical uncertainty.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently a major focus for investors as the community eagerly awaits the Phase 3 IZAR-1 trial results, which management previously indicated would be released within a one-month window that has now passed. Despite significant institutional interest and anticipation of potential best-in-class data, the stock is experiencing volatile price action and ongoing debate among market participants regarding the timing of the readout and the company's communication strategy.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending as investors aggressively buy the dip following a sharp recovery in the AI infrastructure sector, fueled by renewed market confidence in compute demand and positive read-throughs from recent hyperscaler earnings. The community is actively discussing the stock's high volatility and potential for a sustained rebound after recent forced liquidations, while maintaining a bullish long-term outlook on the company's critical role in the AI ecosystem.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CLF BACLAYS ISSUES A SELL RECOMENADTION   
                 PRICE TARGET ?

Michael P Madden

StockTwits Web

Cleveland-Cliffs Inc

 BACLAYS ISSUES A SELL RECOMENADTION   
                 PRICE TARGET ?